Objectives: To compare general and spinal anesthesia in the context of thromboembolic disease after orthopedic surgery in patients receiving prophylactic therapy with low molecular weight heparins.

Patients And Method: Of the 484 arthroplasties studied retrospectively, 209 involved total hip prostheses, 111 partial hip prostheses and 164 total knee prostheses. Spinal anesthesia (epidural or subarachnoid) was provided in 328 cases and general anesthesia in 156. Thromboembolic disease was diagnosed if the patient presented a compatible clinical picture or if there was confirmation by Doppler ultrasonography and/or venography for deep venous thrombosis or by scintigraphy for pulmonary embolism. Related factors studied were age; weight; prior fractures of the lower extremity; a history of thromboembolism, diabetes, high blood pressure or heart disease; and medication.

Results: Twenty-one patients experienced thromboembolic complications, 12 after general anesthesia and 9 after spinal anesthesia, the incidence in the latter being significantly lower (p < 0.01, odds ratio 3.23, 95% CI). Multivariant analysis also showed a significant increase in thromboembolic disease (p = 0.05) among patients over 70 years of age (odds ratio 2.67, 95% CI).

Conclusions: Spinal anesthesia provides some protection against thromboembolic disease in arthroplasty. Age is a risk factor.

Download full-text PDF

Source

Publication Analysis

Top Keywords

thromboembolic disease
20
spinal anesthesia
16
hip prostheses
8
general anesthesia
8
odds ratio
8
thromboembolic
6
disease
6
anesthesia
6
[spinal anesthesia
4
anesthesia protective
4

Similar Publications

Background: Venous thromboembolism (VTE) and atrial fibrillation (AF) disproportionately affect older adults, who are at increased risk of bleeding from treatment with anticoagulant therapy. The impact of bleeding on older adults' quality of life (QoL) is poorly understood due to the lack of a validated measure of their experience. This study's purpose is to describe the first evidence-based steps in developing a new condition-specific patient-reported outcome measure (PROM) for the effect of anticoagulant-related bleeding on older adults' QoL.

View Article and Find Full Text PDF

Perioperative Venous Thromboembolism Prophylaxis in Orthopedic Trauma: A Practical Review.

R I Med J (2013)

February 2025

Division of Trauma and Surgical Critical Care, The Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island.

Background: Orthopedic trauma patients are at high risk for venous thromboembolic (VTE) complications. Despite this, VTE prophylaxis is often held peri-operatively out of concern for increased bleeding and associated complications. This review's purpose is to examine guidelines and studies on withholding prophylactic anticoagulation peri-operatively.

View Article and Find Full Text PDF

Background: Tranexamic acid is an anti-fibrinolytic agent routinely used during hip and knee joint replacement surgery to minimize bleeding. Chronic kidney disease is a common chronic health problem seen among adults requiring major arthroplasty surgery. Tranexamic acid is renally cleared and may accumulate in chronic kidney disease.

View Article and Find Full Text PDF

Objective: This study aimed to compare perioperative outcomes and progression-free and overall survival in patients with chronic kidney disease (CKD) versus those without after hyperthermic intra-peritoneal chemotherapy (HIPEC) for ovarian cancer.

Methods: This is a retrospective, single-institution cohort study of patients with ovarian cancer treated with HIPEC at the Cleveland Clinic from January 2009 to December 2022. All patients received HIPEC with cisplatin and renal protection with mannitol and furosemide.

View Article and Find Full Text PDF

Limited available evidence comparing DOACs with warfarin suggests efficacy and safety of DOACs for CVT. We aimed to evaluate whether a specific DOAC is preferred for the treatment of CVT. This retrospective cohort study included adult patients with CVTs between September 2018 and September 2022 treated with a DOAC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!